CA2601640C - Use of macrolides for treating intestinal inflammation - Google Patents

Use of macrolides for treating intestinal inflammation Download PDF

Info

Publication number
CA2601640C
CA2601640C CA2601640A CA2601640A CA2601640C CA 2601640 C CA2601640 C CA 2601640C CA 2601640 A CA2601640 A CA 2601640A CA 2601640 A CA2601640 A CA 2601640A CA 2601640 C CA2601640 C CA 2601640C
Authority
CA
Canada
Prior art keywords
formula
compound
pharmaceutically acceptable
disease
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2601640A
Other languages
English (en)
French (fr)
Other versions
CA2601640A1 (en
Inventor
Mario Del Tacca
Corrado Blandizzi
Gabriele Morazzoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of CA2601640A1 publication Critical patent/CA2601640A1/en
Application granted granted Critical
Publication of CA2601640C publication Critical patent/CA2601640C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA2601640A 2005-03-21 2006-03-14 Use of macrolides for treating intestinal inflammation Expired - Fee Related CA2601640C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05102244 2005-03-21
EP05102244.0 2005-03-21
PCT/EP2006/060709 WO2006100195A1 (en) 2005-03-21 2006-03-14 Use of macrolides for treating intestinal inflammation

Publications (2)

Publication Number Publication Date
CA2601640A1 CA2601640A1 (en) 2006-09-28
CA2601640C true CA2601640C (en) 2013-10-22

Family

ID=36649815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2601640A Expired - Fee Related CA2601640C (en) 2005-03-21 2006-03-14 Use of macrolides for treating intestinal inflammation

Country Status (12)

Country Link
US (1) US20080249034A1 (cg-RX-API-DMAC7.html)
EP (1) EP1868619A1 (cg-RX-API-DMAC7.html)
JP (1) JP2008533186A (cg-RX-API-DMAC7.html)
CN (1) CN101212980A (cg-RX-API-DMAC7.html)
AU (1) AU2006226381B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0614009A2 (cg-RX-API-DMAC7.html)
CA (1) CA2601640C (cg-RX-API-DMAC7.html)
EA (1) EA012309B1 (cg-RX-API-DMAC7.html)
IT (1) ITMI20060460A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007011544A (cg-RX-API-DMAC7.html)
WO (1) WO2006100195A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200708423B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1907406T3 (pl) 2005-07-06 2010-10-29 Zambon Spa Krystaliczne postacie związków makrolidowych wykazujące aktywność przeciwzapalną
WO2008065636A2 (en) * 2006-12-01 2008-06-05 University College York - National University Of Ireland, Cork Treatment of disease by modulating cf5 protein
CN117750889A (zh) * 2021-02-26 2024-03-22 潘思瑞公司 稳定的初乳组合物
CN113209084A (zh) * 2021-05-18 2021-08-06 南开大学 化合物cp0119在制备用于治疗炎性肠病的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2089219C1 (ru) * 1994-02-22 1997-09-10 Александра Леонидовна Бурмистрова Способ лечения неспецифического язвенного колита
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria

Also Published As

Publication number Publication date
ITMI20060460A1 (it) 2006-09-22
BRPI0614009A2 (pt) 2011-03-01
EP1868619A1 (en) 2007-12-26
WO2006100195A1 (en) 2006-09-28
MX2007011544A (es) 2008-03-11
EA012309B1 (ru) 2009-08-28
AU2006226381A1 (en) 2006-09-28
JP2008533186A (ja) 2008-08-21
US20080249034A1 (en) 2008-10-09
AU2006226381B2 (en) 2011-09-08
EA200702036A1 (ru) 2008-02-28
CN101212980A (zh) 2008-07-02
ZA200708423B (en) 2009-03-25
CA2601640A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
US5814625A (en) Chemoprevention of metachronous adenomatous colorectal polyps
EP1031350A1 (en) Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
JP2014076998A (ja) 医薬組成物
JP2000507938A (ja) 結腸直腸の化学的保護のためのウルソデオキシコール酸化合物及びnsaidの組合せ
JP2587441B2 (ja) 製薬学的組成物
AU2006226381B2 (en) Use of macrolides for treating intestinal inflammation
WO1990006108A1 (fr) Agent anti-inflammatoire polyvalent
CN105079012B (zh) 天麻素在制备防治溃疡性结肠炎的药物或食品中的应用
WO2016121147A1 (ja) 注腸剤
CN104983728B (zh) 金合欢素在制备防治溃疡性结肠炎的药物或食品中的应用
WO2024078468A1 (zh) 二苯乙烯衍生物用于预防和或治疗溃疡的用途
PT2106258E (pt) Ibuprofeno contra a tosse
CN112826820B (zh) Nlrp3抑制剂及其应用
JP2018108993A (ja) 注腸剤
CN117379423A (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
AU2008257319B2 (en) Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
CN105147661A (zh) 升麻素在制备防治溃疡性结肠炎的药物或食品中的应用
CN105078960A (zh) 芫花素在制备防治溃疡性结肠炎的药物或食品中的应用
RU2057530C1 (ru) Способ лечения язвы желудка в эксперименте
CN101014333A (zh) 包含洛索洛芬的口服组合物
ES2357245T3 (es) Inhibidor de los pólipos intestinales.
CN114306299A (zh) 贝利司他在制备缓解和/或治疗缺血性脑卒中药物中的应用
CN121891377A (zh) 一种包含氟比洛芬酯的药物组合物及其应用
WO2004058048A2 (en) Dehydroepiandrosterone (dhea) congeners for prevention and/or treatment of ulcers
US20080076827A1 (en) Treatment of Inflammatory Bowel Disease

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20160314